AstraZeneca Plc said a “careful” review of all available data of the more than 17 million people in the European Union and the U.K. it has vaccinated against so far against Covid-19 shows no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia.
The company says it is continually monitoring the safety of its vaccine.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
GFA boss Kurt Okraku graces Dreams FC’s dinner to celebrate CAF Confederation Cup exploits
2 mins -
We’ve intensified efforts to combat misinformation, hate speech ahead of elections- Akufo-Addo
4 mins -
Sekondi-Takoradi: STMA/Joy News’ ‘Operation Clean Your Surroundings’ taskforce arrest 10 for open defecation
20 mins -
Joy Prime’s Prime Morning celebrates May Day with gallant Officers of Ghana Navy
31 mins -
YAWC Network Ghana chapter holds National summit in Accra
48 mins -
Memories of a Baby Univers
59 mins -
Akufo-Addo calls for peaceful elections, says politics shouldn’t divide us
1 hour -
Yinson, West African Rescue Association and Ahanta West Municipality tackle malaria
1 hour -
NHIA releases over GHS170m to settle healthcare providers
2 hours -
GFA will continue to support clubs in Africa – Kurt Okraku promises
2 hours -
Oheneyere Mrs. Helen Opong-Kesse
2 hours -
University of Ghana Stadium to host WAFU B U-17 Cup of Nations
2 hours -
Support us to demand better conditions of service – TEWU OF TUC tells members
2 hours -
CAFCC: Dreams FC holds dinner to honour players for reaching the semi-finals
2 hours -
200 students selected for KNUST e-learning ambassador training
2 hours